Opinion

Video

Atopic dermatitis Clinical Trial Endpoints

An atopic dermatitis expert discusses the primary and secondary efficacy endpoints and treatment goals commonly assessed in clinical trials for moderate to severe atopic dermatitis.

  1. Please share primary and secondary efficacy outcomes/treatment targets routinely examined in atopic dermatitis clinical trials for moderate to severe atopic dermatitis.
  2. Is there consensus amongst experts on treatment targets? 
Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
Safety Profile, Accessibility of Tapinarof Cream for Atopic Dermatitis, with Adelaide Hebert, MD
Impact of Tapinarof Cream Approval for Atopic Dermatitis, with Adelaide Hebert, MD
Sobia Laique, MD | Credit: Cleveland Clinic
Sobia Laique, MD | Credit: Cleveland Clinic
What is the Global Lung Function Initiative and Its Purpose for Lung Function Testing?
© 2025 MJH Life Sciences

All rights reserved.